Primobolan (Methenolone Enanthate): Cycle, Dosage, Real Expectations

Primobolan (Methenolone Enanthate): Cycle, Dosage, Real Expectations

TL;DR

• Primobolan is a DHT-derived injectable that does not aromatise, so there is no water retention, no estrogenic blood pressure rise, and essentially no gynecomastia risk from the compound itself.
• The anabolic effect is genuinely mild: expect slow, lean, high-quality gains or muscle retention on a deficit — not dramatic scale changes. Anyone promising otherwise is overselling it.
• Common practice doses run 300–600 mg per week for men, split into two injections; the enanthate ester has a half-life of roughly 7–10 days, so two injections weekly keep levels stable.
• Typical cycle length is 10–14 weeks, often with a testosterone base; Primobolan still suppresses natural testosterone, so PCT is required.
• It is one of the most counterfeited compounds on the market — bloodwork mid-cycle is the only reliable way to confirm the product is real.
• Side effects are comparatively moderate but real: HDL suppression, HPTA shutdown, and hair loss acceleration in those predisposed to male-pattern baldness.

What Primobolan Is

Methenolone enanthate is a dihydrotestosterone (DHT) derivative — methenolone bound to the enanthate ester, which slows release from the intramuscular depot over roughly a week to ten days. As a DHT derivative, it cannot be converted to oestradiol by the aromatase enzyme. That single fact defines the entire character of the compound: no estrogenic side effects, no water retention, and a "dry" look that made it a classic pre-contest drug.

Its anabolic-to-androgenic ratio is often quoted around 88:50 — meaning it is weaker as a pure anabolic than testosterone itself, and moderately androgenic on paper, though the practical androgenic impact is gentler than the numbers suggest. Methenolone was used clinically in Europe for decades (including in children with growth failure and patients with muscle wasting), which tells you two things: it has a well-documented safety record at therapeutic doses, and its anabolic punch at those doses is modest. It is not a mass builder. It never was.

Effects and Real Expectations

This is where marketing and reality diverge most sharply. Primobolan does three things well:

• Lean tissue retention in a caloric deficit. This is its strongest use case. On a cut, it helps hold muscle and strength while fat comes off, with no water masking the result.
• Slow, clean gains in a slight surplus. Users at 400–600 mg/week report steady quality gains — a kilogram or two of actual tissue over a cycle, not the rapid (and largely fluid) jumps seen with aromatising compounds.
• A hard, dry appearance. No subcutaneous water means whatever condition you have is fully visible.

What it does not do: transform a beginner's physique, add ten kilograms of muscle, or substitute for testosterone as a cycle foundation at typical doses. If you are comparing it to other DHT-derived "cosmetic" compounds, the honest differences are laid out in Primobolan Vs Masteron DHT Derivatives For Recomp And Cutting — Masteron is cheaper and drier, Primobolan is milder and slightly more anabolic, and neither is a mass compound.

The counterfeiting problem deserves emphasis: because genuine methenolone raw material is expensive, Primobolan is among the most frequently faked or underdosed steroids sold, often substituted with testosterone propionate or boldenone. If your "Primo" cycle produces sudden water retention, acne, and libido spikes, that is a red flag the vial contains something else.

Dosage and Administration

The enanthate ester's half-life of roughly 7–10 days means two injections per week are sufficient for stable blood levels — Monday/Thursday is the standard rhythm. Most preparations come at 100 mg/ml, which means injection volume adds up quickly at higher doses: 600 mg/week is 3 ml per injection at that concentration, so site rotation (glutes, ventrogluteal, delts, quads) matters.

Two honest observations. First, below 300 mg/week, the suppression cost often outweighs the visible return for most men — you shut down natural production for little gain. Second, the jump from 400 to 600 mg/week is noticeable; the jump from 600 to 800 mg mostly increases cost and lipid impact. Dose-response flattens fast with this compound.

On the product side, concentration is almost universally 100 mg/ml. Ampoule formats like Methenolone Enanthate 100mg/ml 10x1ml Ampoules by Elbrus Pharmaceuticals offer single-dose sterility assurance at the cost of more frequent opening and drawing, while multi-dose vials such as Methenolone Enanthate 100mg/ml 10ml Vial by Hilma Biocare are more economical across a 12-week cycle. The full selection is grouped in the Methenolone Enanthate category. Whichever format you choose, budget realistically: a 600 mg/week, 12-week cycle requires 72 ml of a 100 mg/ml preparation — this is an expensive compound to run properly, which is precisely why underdosed versions flood the market.

Cycle Planning

Primobolan's long ester saturates slowly — noticeable effects typically arrive around weeks 4–6 — so cycles shorter than 10 weeks waste the build-up phase. Ten to fourteen weeks is the rational window.

A key structural decision: solo or with a testosterone base. Running methenolone alone means suppressed natural testosterone with no replacement, and some users report low-oestrogen symptoms (flat mood, joint aches, low libido) because methenolone contributes no oestradiol. A common practice solution is a modest testosterone base of 150–250 mg/week alongside 400–600 mg of Primobolan, which keeps oestradiol in a healthy range without much water retention. The principles of structuring that base — dosing rhythm, clearance timing, PCT planning — are covered in Testosterone Enanthate Cycle Guide.

PCT timing follows the same long-ester logic as testosterone enanthate: start roughly two weeks after the final injection, once serum levels have fallen. A four-week SERM protocol (tamoxifen 20 mg/day or enclomiphene 12.5–25 mg/day) is standard, verified by bloodwork three to four weeks afterward.

Side Effects and Risks

Primobolan's reputation as "the safe steroid" is exaggerated, but its side-effect profile is genuinely among the mildest of the injectables. What remains on the table:

• Suppression. Guaranteed, not optional. Natural testosterone production shuts down within weeks even at moderate doses. PCT is not negotiable.
• Lipids. HDL cholesterol suppression is the compound's main cardiovascular cost — often a 20–30% drop at 400–600 mg/week. Less severe than with oral steroids, but meaningful and worth tracking.
• Androgenic effects. As a DHT derivative, methenolone can accelerate male-pattern baldness in the genetically predisposed, and there is no finasteride workaround — the molecule itself is the androgen. Acne and oily skin occur at higher doses but are usually mild.
• No estrogenic effects. No aromatisation means no gyno, no estrogenic water retention, no estrogenic blood pressure rise from the compound itself. (If a testosterone base is included, its aromatisation still applies.)
• Injection burden. High volumes at 100 mg/ml concentration mean more frequent or larger injections; post-injection pain beyond 72 hours, redness, warmth, or fever indicates possible infection and needs medical attention.
• Counterfeit risk. As noted above, the dominant real-world risk may be that the vial does not contain methenolone at all.

Who should not run it: anyone under roughly 25, anyone with pre-existing lipid abnormalities or uncontrolled blood pressure, anyone unwilling to do bloodwork and PCT, and — candidly — anyone whose budget only stretches to suspiciously cheap Primobolan. Cheap Primo is usually not Primo.

Bloodwork and Monitoring

The monitoring protocol is lighter than for aromatising compounds but not optional:

• Baseline: total/free testosterone, LH, FSH, lipid panel, liver enzymes (ALT, AST, GGT — injectable methenolone is not hepatotoxic, but a baseline matters), haematocrit, blood pressure.
• Mid-cycle (week 6–7): total testosterone to verify the product is real and dosed (levels should sit well above reference range), oestradiol (especially if running a testosterone base), and lipids — HDL is the marker that moves with this compound.
• Post-PCT (week 20–22): LH, FSH, total testosterone to confirm the axis has restarted, plus lipids to confirm HDL has recovered toward baseline.

The mid-cycle draw doubles as authentication: given the counterfeiting rate, bloodwork is the closest thing to a lab assay most users will ever get.

FAQ

Is Primobolan good for a first cycle?

It is one of the gentler options in terms of side effects, but it is a poor value as a first cycle: the gains at beginner doses are modest, suppression still occurs, and genuine product is expensive. Most beginners get far more return per unit of suppression from a testosterone-only cycle. Primobolan makes more sense later, when the goal shifts to lean retention or refinement rather than raw growth.

Can women use Primobolan?

Methenolone has historically been considered one of the lower-virilisation-risk anabolics, and low doses (50–100 mg/week) have been used by female competitors. However, virilisation — voice deepening, clitoral enlargement, facial hair growth — is still possible and partly irreversible. Any woman considering it should understand that risk plainly and start at the lowest end, stopping immediately at the first signs.

Do I need an aromatase inhibitor on a Primobolan cycle?

If methenolone is run alone, no — it does not aromatise, so there is nothing to inhibit. If a testosterone base is included, AI decisions depend on that component's dose and should be driven by mid-cycle oestradiol bloodwork, not prophylactic dosing. Crashing oestradiol on a "mild" cycle is a common self-inflicted error.

Why am I not seeing results at week 4?

Because the enanthate ester saturates slowly and the compound's effects are subtle by nature. Visible changes typically start around weeks 4–6 and accumulate gradually. If you have reached week 8 at 400+ mg/week with no change in strength, body composition, or bloodwork markers, suspect underdosed or substituted product — this happens frequently with Primobolan specifically.

Is Primobolan worth the price compared to Masteron?

They serve overlapping but distinct purposes. Primobolan is slightly more anabolic and milder on lipids; Masteron is cheaper, drier, and more cosmetic but offers less tissue retention. For pure muscle-sparing on a deficit, Primobolan has the edge; for hardening on an already-lean physique, Masteron often wins on cost. Many advanced users simply pick whichever fits the budget.

Conclusion

Primobolan earns its reputation only when expectations are calibrated: it is a mild, non-aromatising compound for lean retention and slow quality gains, not a mass builder, and its results are measured in condition and kept tissue rather than kilograms. The honest risk summary: full HPTA suppression requiring PCT, meaningful HDL cholesterol suppression at effective doses, accelerated hair loss in the predisposed, and a counterfeit market that makes verification by bloodwork essential. Do not run it if you are under roughly 25, if your baseline lipids or blood pressure are already abnormal, or if you cannot commit to the three blood draws — baseline, mid-cycle, post-PCT — that make the cycle legible. And be sceptical of bargains: with this compound above all others, an implausibly low price is itself a safety signal. Respect those constraints, and Primobolan is one of the more manageable tools available; ignore them, and you carry all the suppression costs of a cycle with none of the certainty about what was actually in the vial.